GFM Network News



Bayer gets U.S. approval to buy Monsanto: report

Reuters — German drugs and pesticides group Bayer has reached a deal with the U.S. Justice Department for antitrust approval for its US$62.5 billion bid to acquire Monsanto by agreeing to sell additional assets, the Wall Street Journal reported Monday. The Justice Department reached an agreement in principle with the two companies in recent days, […] Read more


Monsanto shareholders back Bayer deal

Chicago | Reuters –– Shareholders of U.S. seeds and agrochemicals company Monsanto approved the company’s US$66 billion acquisition by Bayer on Tuesday, a deal that still requires regulatory approval to close as expected in late 2017. Increased research and development spending by the combined companies and plans to develop a global seeds and biotechnology hub […] Read more

Fertilizer merger faces easier approval at home than in U.S.

Toronto/Washington | Reuters — Canada’s PotashCorp and Agrium are more likely to win approval for a potential merger in Canada than in the U.S., but U.S. rejection of the deal would scuttle it globally, competition lawyers said. Saskatoon-based PotashCorp and Calgary’s Agrium confirmed Tuesday they were in preliminary merger talks, toward a deal that would […] Read more





DuPont expects U.S. review of Dow deal to end by June 30

Reuters — DuPont said Tuesday it expected the U.S. Securities and Exchange Commission’s review of its proposed merger with Dow Chemical to be completed by the end of June. The two chemical companies agreed to combine in an all-stock merger in December, valued at US$130 billion at the time, in a first step towards breaking […] Read more

U.S. farm, consumer groups aim to block Monsanto bid for Syngenta

Reuters — Several U.S. farm and consumer groups are working on strategies to derail a proposed tie-up of Monsanto and agricultural seeds and chemicals rival Syngenta, saying a combination of the market leaders would spell fewer and higher-priced products. Coalitions of opponents are being formed and market analyses being done, moves that underscore the hurdles […] Read more